Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) NeoMercazole 5mg tablets (Amdipharm Limited)
Section 19A approved medicine
(Approval lapsed) NeoMercazole 5mg tablets (Amdipharm Limited)
Section 19A approval holder
Boucher & Muir Pty Ltd t/a ADVANZ PHARMA ABN 58 000 140 474
Phone
1800 627 680
Approved until
Status
Expired
Medicines in short supply/unavailable
NEO-MERCAZOLE carbimazole 5mg tablet bottle - ARTG 194296
Indication(s)
Therapy of hyperthyroidism. Definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. Preparation for thyroidectomy. Before and after radioactive iodine treatment.